CSA Biotechnology Fund II, LLC — Form D/A
CSA Biotechnology Fund II, LLC of BIRMINGHAM, AL, a company, filed a Form D amendment with the SEC on 2009-11-24. The offering totals $10.0M, of which $8.6M was reported sold. Industry: Investment Banking.
Offering
- Filed: 2009-11-24
- Form: D/A
- Accession: 0001477399-09-000004
- Industry: Investment Banking
- Exemptions: 06
- Total offering: $10.0M
- Amount sold: $8.6M
- Remaining: $1.4M
- Minimum investment: $25K
- Investors: 58
- Date of first sale: 2008-02-28
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-136347
Issuer
- Name: CSA Biotechnology Fund II, LLC
- CIK: 0001477399
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: Two Metroplex Drive, BIRMINGHAM, AL, 35209
- Phone: 2052632332
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Hollis N Gieger | Executive Officer | Birmingham, AL |
| Madding King III | Executive Officer | Birmingham, AL |
| J. Rainer Twiford | Executive Officer | Birmingham, AL |
| J. Rainer Twiford | Executive Officer | Birmingham, AL |
| Hollis Gieger | Executive Officer | Birmingham, AL |
Other filings by this issuer (1)
More